Supernus Pharma News, Supernus Pharma Quote, SUPN Quote

Supernus Pharma (NQ:SUPN) Delayed: 29.27 +0.40 (1.39%)

Prev. Close

$28.87

Open

$28.67

52 Wk High

$26.84

52 Wk Low

$9.51

Day High

$29.51

Day Low

$28.67

P/E

N/A

EPS

$-2.62

Volume

127,199

Friends, Peers and Foes (?): GUD (more...)

Apr 8, 2024 10:10 AM Jefferies on Supernus (SUPN): 'We expect a -5-10% stock reaction after the FDA's rejection of SPN-830'
Apr 8, 2024 10:09 AM Stifel on Supernus Pharmaceuticals (SUPN): 'SPN-830 Approval Delayed Again, but Near-Term Impact Relatively Minor'
Apr 8, 2024 08:05 AM Supernus Pharma (SUPN) Provides Regulatory Update for SPN-830, FDA Issues CRL
Apr 8, 2024 08:04 AM Form 8-K SUPERNUS PHARMACEUTICALS For: Apr 08
Apr 8, 2024 08:01 AM Supernus Provides Regulatory Update for SPN-830
Mar 25, 2024 05:00 PM Form 4 SUPERNUS PHARMACEUTICALS For: Mar 21 Filed by: Bhatt Padmanabh P.
Mar 22, 2024 05:01 PM Form 4 SUPERNUS PHARMACEUTICALS For: Mar 20 Filed by: Bhatt Padmanabh P.
Mar 21, 2024 05:03 PM Form 4 SUPERNUS PHARMACEUTICALS For: Mar 19 Filed by: Bhatt Padmanabh P.
Mar 19, 2024 04:21 PM Form 144 SUPERNUS PHARMACEUTICALS Filed by: Bhatt Padmanabh P.
Mar 15, 2024 06:39 PM Form 4 SUPERNUS PHARMACEUTICALS For: Mar 13 Filed by: Bhatt Padmanabh P.

Entities mentioned with SUPN